Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shuvra Kanti Dey has a total of 128 co-authors. Here are the top co-authors by number of shared publications:

  • Nadim Sharif

    Department of Microbiology, Jahangirnagar University, Savar, Dhaka, 1342, Bangladesh

    34 shared publications
  • Ali Azam Talukder

    Department of Microbiology, Jahangirnagar University, Savar, Dhaka, Bangladesh

    12 shared publications
  • Afsana Khan

    Department of Statistics, Jahangirnagar University, Savar, Dhaka, 1342, Bangladesh

    10 shared publications
  • Anowar Khasru Parvez

    Department of Microbiology, Jahangirnagar University, Dhaka, Bangladesh

    9 shared publications
  • Hiroshi Ushijima

    Division of Microbiology, Department of Pathology and Microbiology, School of Medicine, Nihon University, Tokyo, Japan

    8 shared publications
  • Fuad M. Alzahrani

    Department of Clinical Laboratories Sciences, College of Applied Medical Sciences, Taif University, Taif, Saudi Arabia

    7 shared publications

Latest Publications

  • Open Access

    Structure-based computational screening and molecular dynamics reveal potential inhibitors of Norovirus VP1 and RdRp Proteins: an in-silico study

    by Hasan Huzayfa Rahaman, Nadim Sharif, Al Imran Kafi, Wasifuddin Ahmed, Nazmul Sharif, Fuad M. Alzahrani, Khalaf F. Alsharif, Khalid J. Alzahrani, Shuvra Kanti Dey

    Norovirus is a major enteric pathogen with pandemic potential and disproportionately high mortality in low-income countries, particularly among young children. Despite its global health burden, no approved vaccine or specific antiviral therapy is currently available. In this study, we targeted two key viral proteins, viral protein 1 (VP1) and RNA-dependent RNA polymerase (RdRp). The workflow included protein modeling, structural stability assessment, molecular docking, molecular dynamics (MD) simulations, non-covalent interaction (NCI) analysis, protein contact atlas evaluation, and pharmacokinetic (ADME-Tox) profiling. Molecular docking results indicated strong binding affinities of selected phytochemicals—Zingiberol, Cardeonolide, Boeravinone B, β-Elemene, and Fisetin—toward both VP1 and RdRp, with binding energies ranging from − 7.8 to − 9.4 kcal/mol. MD simulations further demonstrated the structural stability of protein–ligand complexes, with stable RMSD values (~ 0.3 nm for RdRp and 0.3–0.5 nm for VP1) and only minor transient fluctuations observed in VP1. RMSF analysis revealed localized flexibility, while radius of gyration, hydrogen bonding patterns, and solvent-accessible surface area collectively confirmed overall conformational stability throughout the simulation period. Complementary protein contact atlas and NCI analyses supported the persistence and robustness of protein–ligand interactions, showing comparable or improved stability relative to reference antivirals ribavirin and nitazoxanide. Additionally, all selected compounds exhibited favorable drug-likeness and acceptable ADME-Tox properties. Collectively, these findings suggest that the identified phytochemicals may serve as promising antiviral candidates against norovirus, although further validation through in vitro and in vivo studies is required.

  • Open Access

    Spatiotemporal trends, evolving seasonality and symptoms of dengue in Bangladesh, 2019-2025

    by Afsana Khan, Nazmul Sharif, Nadim Sharif, Shuvra Kanti Dey


  • Open Access

    Emergence of human enteric adenovirus F41 among children with gastroenteritis in North-central Bangladesh, 2022–2024

    by Nadim Sharif, Abdullah Ibna Masud, Jannatin Naim, Rubayet Rayhan Opu, Afsana Khan, Khalid J. Alzahrani, Khalaf F. Alsharif, Fuad M. Alzahrani, Hiroshi Ushijima, Shuvra Kanti Dey

    Human adenovirus F-41 (HAdV-F41) is an emerging cause of pediatric gastroenteritis, but data from South Asia remain limited. We investigated the molecular epidemiology, clinical features, seasonality of adenovirus-associated gastroenteritis and feasibility of an immunochromatography (IC) kit among children under 5 in north-central Bangladesh during July 2022-June 2024. Fecal samples from 360 children with acute gastroenteritis were tested for viral and bacterial pathogens using PCR, sequencing, and phylogenetic analyses. HAdV was detected in 7% (25/360) of cases, which was the second most common virus after rotavirus. Most adenovirus-positive samples (76%, 19/25) were adenovirus F-41. Infected children, aged 12-35 months, exhibited more severe gastrointestinal symptoms, including dehydration and severe vomiting. Infections peaked during colder months and were correlated with temperature. Study strains were closely related with contemporary global adenovirus F-41 strains. A rapid immunochromatographic assay for HAdV demonstrated high agreement with PCR. These findings identify adenovirus F-41 as an emerging contributor to pediatric gastroenteritis in Bangladesh and highlight the need for enhanced surveillance.

  • Open Access

    In silico prediction, molecular docking and simulation of natural flavonoid apigenin and xanthoangelol E against human metapneumovirus

    by Hasan Huzayfa Rahaman, Afsana Khan, Wasifuddin Ahmed, Nazmul Sharif, Rista Majumder, Silvia Aparicio Obregon, Rubén Calderón Iglesias, Isabel De la Torre Díez, Shuvra Kanti Dey

    The online version contains supplementary material available at 10.1007/s40203-025-00539-7.


  • Open Access

    Structure-based computational screening and molecular dynamics reveal potential inhibitors of Norovirus VP1 and RdRp Proteins: an in-silico study

    by Hasan Huzayfa Rahaman, Al Imran Kafi, Wasifuddin Ahmed, Nazmul Sharif, Fuad M. Alzahrani, Khalaf F. Alsharif, Khalid J. Alzahrani, Shuvra Kanti Dey

    Norovirus is recognized as a pathogen with pandemic potential, exhibiting a higher fatality rate in low-income countries, particularly affecting young children. Currently, vaccine or specific antiviral treatment for norovirus is lacking. For evaluating antiviral compounds, this study was conducted by targeting viral protein 1 (VP1) and RNA-dependent RNA polymerase (RdRP) proteins through in silico approach, which included modeling protein, assessment stability, molecular docking, molecular simulation, non-covalent interaction (NCI) analysis, and pharmacokinetic profiling. Higher binding affinity revealed by molecular docking (-7.8 kcal/mol to -9.4 kcal/mol) for the ligands Zingiberol, Cardeonolide, Boeravinone B, Beta-Elemene, and Fisetin with VP1 and RdRp. The molecular dynamic simulation and subsequent analyses demonstrated significantly expected stable docked complexes of the protein-ligand in comparison to the ribavirin antiviral drug. Furthermore, these ligands exhibited acceptable drug-likeness and ADME-Tox (absorption, distribution, metabolism, excretion, and toxicity) profiles. This study initially suggests that these compounds have potentiality as antiviral candidates, warranting wet lab experiment to be considered for norovirus infection.


  • Open Access

    Trends of Human Metapneumovirus Outbreaks in Bangladesh: Probable Risks and Preventive Strategies

    by Nadim Sharif, Shuvra Kanti Dey

    Background and Aims: Human metapneumovirus (hMPV) is one of the major pathogens associated with respiratory tract infection and is a rising concern for people with compromised immunity worldwide. Amid the global concern about the increased incidence of hMPV, we found a significant lack of studies on the epidemiology of this virus in Bangladesh. Methods: In this study, we integrated the previous reports of hMPV in Bangladesh and characterized the cases. Results: We found that hMPV has been continuously circulating since 2000 among the residents of Bangladesh. The prevalence varied from 3.9% to 33% among children aged below 5 years. The cases were reported from Dhaka, Chittagong, Cumilla, Bogura, and Barishal. Among the symptoms, fever (80%–100%), cough (85%–100%), tachypnea (70%–100%), runny nose (80%–97%), and difficulty breathing (70%–85%) were the most common. Conclusion: This is the first integrated study of hMPV outbreak characterization in Bangladesh.

  • Open Access

    Natural flavonoid apigenin and xanthoangelol E are potent antivirals against human metapneumovirus: an in-silico study

    by Hasan Huzayfa Rahaman, Wasifuddin Ahmed, Nazmul Sharif, Rista Majumder, Silvia Aparicio Obregon, Rubén Calderón Iglesias, Isabel Torre Díez, Shuvra Kanti Dey

    Human metapneumovirus (hMPV) is one of the potential pandemic pathogens, and it is a concern for elderly subjects and immunocompromised patients. There is no vaccine or specific antiviral available for hMPV. We conducted an in-silico study to develop antivirals against human metapneumovirus. Our methodology included protein modeling, stability assessment, molecular docking, molecular simulation, analysis of non-covalent interactions, bioavailability, carcinogenicity, and pharmacokinetic profiling. We pinpointed four plant-derived bio-compounds as antiviral candidates. Among the compounds, apigenin showed the highest binding affinity, with values of -8.0 kcal/mol for the hMPV-F protein and -7.6 kcal/mol for the hMPV-N protein. Molecular dynamic simulations and further analyses confirmed that the protein-ligand docked complexes exhibited significantly acceptable stability compared to two standard antiviral drugs. Additionally, these four compounds yielded satisfactory outcomes in bioavailability, drug-likeness, and ADME-Tox (absorption, distribution, metabolism, excretion, and toxicity) and STopTox analyses. This study highlights the highest potential of apigenin and xanthoangelol E as effective antivirals, underscoring the necessity for preclinical and clinical trials and wet-lab evaluation to consider them as treatments for human metapneumovirus infection.

  • Open Access

    In silico prediction, molecular docking and simulation of antiviral compounds against major proteins of Nipah virus

    by Hasan Huzayfa Rahaman, Rista Majumder, Nazmul Sharif, Perla Araceli Arroyo Gala, Thania Candelaria Chio Montero, Fuad M. Alzahrani, Khalaf F. Alsharif, Khalid J. Alzahrani, Isabel De la Torre Díez, Shuvra Kanti Dey

    Nipah virus (NiV) is one of the pandemic potential pathogens with a higher case fatality rate of around 80%. There is no vaccine or specific antiviral available for NiV. We performed this study to evaluate antiviral compounds against NiV-G, NiV-F, NiV-M, NiV-P, NiV-N, and NiV-W proteins through in silico analysis including protein modeling, stability checking, molecular docking, molecular simulation, non-covalent interactions, bioavailability, and pharmacokinetics profiling. Molecular docking provided higher binding affinity (-9.0 kcal/mol to -10.4 kcal/mol) among ligand CID71721532 (PubChem ID) and NiV-G, NiV-M, NiV-F, and NiV-P proteins. Another ligand CID11395956 (PubChem ID) demonstrated the lowest binding energies at -8.7 kcal/mol and -9.5 kcal/mol for NiV-W and Niv-N, respectively. The molecular dynamic simulation and further analysis provided significantly acceptable stability of the protein-ligand docked complexes compared to the antiviral favipiravir. Furthermore, these two compounds provided acceptable values in bioavailability, drug-likeness, ADME-Tox (absorption, distribution, metabolism, excretion, and toxicity) and STopTox analyses. This study suggests the potentiality of these compounds as suitable antivirals which need preclinical and clinical trials and wet lab evaluation to be considered as drugs for Nipah virus infection.


  • Open Access

    Antimicrobial resistant enteric bacteria are widely distributed among environmental water sources in Dhaka, Bangladesh

    by Nadim Sharif, Rubayet Rayhan Opu, Tama Saha, Afsana Khan, Fuad M. Alzahrani, Meshari A. Alsuwat, Roger Sarín Rivas Suárez, Eduardo Garcia Villena, Khalid J. Alzahrani, Shuvra Kanti Dey


  • Open Access

    Clinical Epidemiology of Dengue and COVID-19 Co-infection Among the Residents in Dhaka, Bangladesh, 2021–2023: A Cross-sectional Study

    by Nadim Sharif, Rubayet Rayhan Opu, Afsana Khan, Tama Saha, Abdullah Ibna Masud, Jannatin Naim, Zaily Leticia Velázquez Martinez, Carlos Osorio García, Meshari A Alsuwat, Fuad M Alzahrani, et al.

    Background: Co-infection of dengue and COVID-19 has increased the health burden worldwide. We found a significant knowledge gap in epidemiology and risk factors of co-infection in Bangladesh. Methods: This study included 2458 participants from Dhaka city from 1 December 2021 to November 30 2023. We performed the Kruskal-Wallis test and χ2 test. Multivariable logistic regression was also performed. Results: Co-infection of dengue and COVID-19 was found among 31% of the participants. Coprevalence of dengue and COVID-19 was found in higher frequency in Jatrabari (14%) and Motijhil (11%). Severe (65%, P = .001) and very severe (78%, P = .005) symptoms were prevalent among the participants aged >50 years. Long-term illness was prevalent among the participants with co-infection (35%; 95% confidence interval [CI], 33–36) and COVID-19 (28%; 95% CI, 26–30). Co-infected participants had a higher frequency of heart damage (31.6%, P = .005), brain fog (22%, P = .03), and kidney damage (49.3%, P = .001). Fever (100%) was the most prevalent symptom followed by weakness (89.6%), chills (82.4%), fatigue (81.4%), headache (80.6%), feeling thirsty (76.3%), myalgia (75%), pressure in the chest (69.1%), and shortness of breath (68.3%), respectively. Area of residence (odds ratio [OR], 2.26; 95% CI, 1.96–2.49, P = .01), number of family members (OR, 1.45; 95% CI ,1.08–1.87; P <.001), and population density (OR, 2.43; 95% CI, 2.15–3.01; P = .001) were associated with higher odds of co-infection. We found that coinfected participants had a 4 times higher risk of developing severe health conditions (OR, 4.22; 95% CI, 4.11–4.67; P = .02). Conclusions: This is one of the early epidemiologic studies of co-infection of dengue and COVID-19 in Bangladesh.